Balance Sheet
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GLAXF) Inventory Average (2017 - 2025)

Gsk has reported Inventory Average over the past 9 years, most recently at $7.6 billion for Q4 2025.

  • Quarterly results put Inventory Average at $7.6 billion for Q4 2025, up 7.49% from a year ago — trailing twelve months through Dec 2025 was $7.6 billion (up 7.49% YoY), and the annual figure for FY2025 was $7.6 billion, up 7.49%.
  • Inventory Average for Q4 2025 was $7.6 billion at Gsk, up from $7.1 billion in the prior quarter.
  • Over the last five years, Inventory Average for GLAXF hit a ceiling of $7.9 billion in Q4 2021 and a floor of $6.4 billion in Q4 2023.
  • Median Inventory Average over the past 5 years was $7.1 billion (2024), compared with a mean of $7.2 billion.
  • Biggest five-year swings in Inventory Average: dropped 11.97% in 2022 and later grew 9.64% in 2024.
  • Gsk's Inventory Average stood at $7.9 billion in 2021, then dropped by 11.97% to $6.9 billion in 2022, then fell by 7.03% to $6.4 billion in 2023, then grew by 9.64% to $7.1 billion in 2024, then rose by 7.49% to $7.6 billion in 2025.
  • The last three reported values for Inventory Average were $7.6 billion (Q4 2025), $7.1 billion (Q4 2024), and $6.4 billion (Q4 2023) per Business Quant data.